ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?

Mostrar otras versiones (1)

BACKGROUND: CD133 and AXL have been described as cancer stem cell markers, and c-MYC as a key regulatory cellular mechanism in colorectal cancer (CRC). AIM: Evaluate the prognostic role of the biomarkers CD133, AXL and c-MYC and their association with clinicopathologic characteristics in colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: CZECZKO, Leticia Elizabeth Augustin, RIBAS, Carmen Australia Paredes Marcondes, CZECZKO, Nicolau Gregori, SKARE, Thelma Larocca, YAMAKAWA, Camila Kienen, GIONEDIS, Guilherme, VASCONCELOS, Cecilia, BREMER, Fabiola Pabst, CASTOLDI, Diogo Francesco, GASSER, Martin, WAAGA-GASSER, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Colégio Brasileiro de Cirurgia Digestiva 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521790/
https://www.ncbi.nlm.nih.gov/pubmed/34669880
http://dx.doi.org/10.1590/0102-672020210002e1585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521790/
https://www.ncbi.nlm.nih.gov/pubmed/34669880
http://dx.doi.org/10.1590/0102-672020210002e1585

Ejemplares similares